Senior insider sale
CMO & EVP Dev & Med Affairs at ALNYLAM PHARMACEUTICALS, INC. — senior position signals high conviction
$1.53M
4.63K shares
What this filing means
GARG PUSHKAL plans to sell 4.63K shares of ALNYLAM PHARMACEUTICALS, INC. valued at approximately $1.53M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/27/2026ACC: 0001969223-26-000253
Officer· CMO & EVP Dev & Med Affairs
Since Dec 2021
4.63K
Shares to sell
$1.53M
Approx. market value
4.63K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
PSU
N/A
2/12/2026
2.34KPSU
N/A
1/11/2026
2.29KTotal acquired4.63K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/12/2026 | PSU N/A | 2.34K | — |
1/11/2026 | PSU N/A | 2.29K | — |
| Total | 4.63K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.63K
Market value
$1.53M
2/27/2026
Total
Units
4.63K
Value
$1.53M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/27/2026 | 4.63K | $1.53M | NASDAQ | Planned |
| Total | 4.63K | $1.53M | ||